Literature DB >> 11035844

Scleral melanocytosis and oculodermal melanocytosis (nevus of Ota) in Chinese children.

A K Leung1, C P Kao, H Y Cho, M P Siu, M C Choi, R S Sauve.   

Abstract

Two thousand nine hundred fourteen Chinese children (1510 males and 1404 females) were examined for the presence of scleral melanocytosis (SM) and oculodermal melanocytosis in a cross-sectional prevalence survey. SM was found in 4.9% of boys and 4.1% of girls under the age of 1 year. The peak prevalence was at 6 years of age, when 44.6% of boys and 46.6% of girls were affected. At 18 years of age, only 11.1% of boys and 13.2% of girls had SM. The overall prevalence, regardless of age, was 27.6% in boys and 27. 1% in girls. The condition was bilateral in 78% of cases. The medial superior quadrant was the most frequently affected site, and the lateral inferior quadrant was the least frequently affected site. Oculodermal melanocytosis occurred only in one patient; the pigmentation affected the left side of the face and the ipsilateral sclera.

Entities:  

Mesh:

Year:  2000        PMID: 11035844     DOI: 10.1067/mpd.2000.108208

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

Review 1.  A comprehensive review of Mongolian spots with an update on atypical presentations.

Authors:  Yusuf Alimi; Joe Iwanaga; Marios Loukas; Rod J Oskouian; Elias Rizk; W Jerry Oakes; R Shane Tubbs
Journal:  Childs Nerv Syst       Date:  2018-08-06       Impact factor: 1.475

2.  Prevalence of ocular and oculodermal melanocytosis in Spanish population with uveal melanoma.

Authors:  E Carreño; M A Saornil; C Garcia-Alvarez; F Lopez-Lara; J M De Frutos-Baraja; A Almaraz
Journal:  Eye (Lond)       Date:  2011-10-21       Impact factor: 3.775

Review 3.  Lasers and nevus of Ota: a comprehensive review.

Authors:  Vidhi V Shah; Fleta N Bray; Adam S Aldahan; Stephanie Mlacker; Keyvan Nouri
Journal:  Lasers Med Sci       Date:  2015-11-12       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.